The Latest Cardiac and Vascular News
PALO ALTO, Calif., Sept. 22, 2022 /PRNewswire/ — DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery. The percutaneous electrical nerve stimulator (PENS) system can be used for up to three days for symptomatic relief of post-operative pain following […]
Clinically relevant doses of C21 increase blood flow in humans Systemic blood pressure was unaffected, and no side effects were observed The forearm blood flow method is a robust technique for early clinical concept testing GOTHENBURG, Sweden, Sept. 22, 2022 /PRNewswire/ — Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing […]
The findings were published in the American Heart Association’s Hypertension journal and showed consistency of program results across diverse populations. MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the only digital therapeutic that focuses exclusively on heart health, has released a new study evaluating the program’s results for various user population groups in order to demonstrate […]
CHICAGO, Sept. 21, 2022 /PRNewswire/ — Cardio Diagnostics, Inc. (“Cardio Diagnostics” or the “Company”), a pioneering precision cardiovascular testing company, today announced that the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation (“UIRF”) U.S. Patent No. 11,414,704 titled COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE, which is exclusively […]
CAMBRIDGE, Mass., Sept. 21, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the clearance of its Clinical Trial Authorisation (CTA) application by the United Kingdom (U.K.) Medicines and Healthcare products Regulatory […]
Getinge announces a supply partnership with Medtronic, which recently received CE mark for the Radiant™ covered stent, the first covered stent indicated for chimney endovascular aneurysm repair (ChEVAR). The Radiant covered stent is a private labeled Advanta V12 balloon expandable covered stent produced by Getinge and distributed by Medtronic. The […]
SHANGHAI, Sept. 20, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM platform, today released the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on Transcatheter Cardiovascular Therapy conference (TCT 2022),one of the world’s most influential cardiovascular conference. PADN is an innovative radiofrequency ablation technique in treating PH, was recognized as […]
New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced positive clinical data at the Transcatheter Cardiovascular Therapeutics Conference (“TCT”) held September 16-19 in Boston. Prof. Shmuel Banai, MD, Neovasc […]
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study NEW HOPE, Pa., Sept. 20, […]
Study of the Paradise™ Ultrasound Renal Denervation System Shows significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension TOKYO–(BUSINESS WIRE)–Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating […]
